Clinical Trials Logo

Clinical Trial Summary

The aim of the study is to investigate how phosphorylation of STAT3, p38 mitogen-activated protein kinase (MAPK), extracellular signal-regulated kinase (ERK) and protein kinase B (AKT) reacts to remote ischemic conditioning (rIC) in healthy humans, which could point to mechanisms by which rIC may protect against ischemia-reperfusion injury (IRI), and if rIC affects immune reactivity.


Clinical Trial Description

In rIC brief episodes of non-lethal ischemia and reperfusion in one vascular bed, tissue or organ, has shown to have protective effects against IRI in various organs. The protective effect of rIC seems convincing, but to date it is not clear which mechanisms give rIC its effects, and why effects are absent in some situations. Effects of rIC on the immune system are also not clear, but important if rIC is used in transplantation and autoimmunity settings, and also in regards to infection risk. Patients studied have often been given medical treatment and/or have comorbidities affecting the results.

This project will measure how intracellular phosphorylation of STAT3, p38 MAPK, ERK and AKT, inflammatory cell patterns and cytokine production react to rIC in healthy humans, and potentially give a better understanding of the mechanisms that mediate the protective effects of rIC. The intracellular mediators studied are involved in the initiation of cytokine production and regulate apoptosis and activation of the inflammatory cells. An altered balance between leucocytes and their mediators could be of importance for rIC effects, particularly in transplantation and autoimmunity, and this will be elucidated in our study.

As a secondary end point the investigators will measure the effect of rIC on pulse variability and blood pressure using a non-invasive device, since evidence regarding these aspects is sparse, although documented positive effects of rIC have primarily been on the heart and vascular system. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03541239
Study type Interventional
Source University of Aarhus
Contact
Status Completed
Phase N/A
Start date March 31, 2016
Completion date July 19, 2016

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06369350 - Vitamin B6 on Exercise Pressor Reflex on Leg Ischemia-reperfusion Early Phase 1
Withdrawn NCT04388761 - Feasibility and Safety of Allogeneic Adipose Mesenchymal Stem Cells (aMSCs) Delivery Into Kidney Allografts Procured From Deceased Donors With High Kidney Donor Profile Index (KDPI) Phase 1
Completed NCT00987974 - Short Term Statin Treatment and Endothelial Dysfunction Due to Ischemia and Reperfusion Injury Phase 4
Recruiting NCT04750616 - NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial Phase 2
Recruiting NCT05992259 - Auricular Vagus Stimulation and STEMI N/A
Completed NCT04493983 - Role of Oxidative Stress in Ovarian Tissue After CO2-pneumoperitoneum Application-induced I/R N/A
Completed NCT03510793 - Microcirculation and Anesthesia in Vascular Surgery
Recruiting NCT02845154 - Intermittent Portal and Graft Purge in Living Donor Liver Transplantation N/A
Terminated NCT01564095 - TOP-Study (Tacrolimus Organ Perfusion): Treatment of Ischemia Reperfusion Injury in Marginal Organs With an ex Vivo Tacrolimus Perfusion Phase 2/Phase 3
Completed NCT03482544 - The Effect of Pregabalin Given Preoperatively on the Tourniquet Induced Ischemia-reperfusion Phase 4
Not yet recruiting NCT05004610 - Hypertonic Lactate After Cardiac Arrest Phase 2
Completed NCT04205253 - Tongue Depressor-related Ischemia-Reperfusion Injury in Tongue
Completed NCT03410576 - Perioperative Time Course of MMP-9 and Its Inhibitor During Carotid Artery Stenting and Carotid Endarterectomy N/A
Completed NCT03743584 - Hypothermia After Cardiac Arrest - Effects on Myocardial Function and Inflammatory Response. N/A
Recruiting NCT04005469 - Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation Phase 1/Phase 2
Recruiting NCT04630535 - OSA as a Remote Ischemic Preconditioning in Vascular Surgery
Completed NCT01610401 - The Metformin-FMD Trial Phase 4
Active, not recruiting NCT00876902 - YSPSL for Prevention of Ischemic Reperfusion Injury in Patients Undergoing Cadaveric Orthotopic Liver Transplantation Phase 2
Recruiting NCT05430620 - Intermittent Versus Continuous Surface O2 During HMP of DCD Kidneys Phase 3
Not yet recruiting NCT03946852 - Abdominal Regional Perfusion in Donation After Cardiac Death for Multi-Organ Transplantation N/A